CN114276384A - Synthetic method of desmethyl olopatadine and its intermediates - Google Patents
Synthetic method of desmethyl olopatadine and its intermediates Download PDFInfo
- Publication number
- CN114276384A CN114276384A CN202210016513.6A CN202210016513A CN114276384A CN 114276384 A CN114276384 A CN 114276384A CN 202210016513 A CN202210016513 A CN 202210016513A CN 114276384 A CN114276384 A CN 114276384A
- Authority
- CN
- China
- Prior art keywords
- solvent
- triphenylphosphine
- organic phase
- olopatadine
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960004114 olopatadine Drugs 0.000 title claims abstract description 35
- 238000010189 synthetic method Methods 0.000 title claims abstract description 23
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 title claims description 31
- 239000000543 intermediate Substances 0.000 title description 20
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims abstract description 87
- 239000002904 solvent Substances 0.000 claims abstract description 82
- 239000012074 organic phase Substances 0.000 claims abstract description 52
- -1 demethyl olopatadine Chemical compound 0.000 claims abstract description 50
- 239000002994 raw material Substances 0.000 claims abstract description 46
- 238000003756 stirring Methods 0.000 claims abstract description 33
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 27
- 229910052751 metal Inorganic materials 0.000 claims abstract description 27
- 239000002184 metal Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 22
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 22
- 238000000605 extraction Methods 0.000 claims abstract description 19
- PQIYSSSTRHVOBW-UHFFFAOYSA-N 3-bromopropan-1-amine;hydron;bromide Chemical compound Br.NCCCBr PQIYSSSTRHVOBW-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003513 alkali Substances 0.000 claims abstract description 17
- 239000007787 solid Substances 0.000 claims abstract description 15
- 239000002274 desiccant Substances 0.000 claims abstract description 14
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 8
- 230000003472 neutralizing effect Effects 0.000 claims abstract description 8
- 239000007789 gas Substances 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 230000001681 protective effect Effects 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 90
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 76
- 238000006243 chemical reaction Methods 0.000 claims description 38
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 38
- 239000002253 acid Substances 0.000 claims description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 30
- 238000010791 quenching Methods 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- 230000000171 quenching effect Effects 0.000 claims description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 20
- 238000001953 recrystallisation Methods 0.000 claims description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 15
- 238000004440 column chromatography Methods 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims description 12
- 229910000105 potassium hydride Inorganic materials 0.000 claims description 12
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 12
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 10
- 230000002194 synthesizing effect Effects 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 8
- 229960001701 chloroform Drugs 0.000 claims description 8
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 239000000741 silica gel Substances 0.000 claims description 7
- 229910002027 silica gel Inorganic materials 0.000 claims description 7
- COPZBGVEAWELFU-UHFFFAOYSA-M 3-(methylamino)propyl-triphenylphosphanium;bromide Chemical group [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCNC)C1=CC=CC=C1 COPZBGVEAWELFU-UHFFFAOYSA-M 0.000 claims description 6
- UPYKKMDXNPTXPZ-UHFFFAOYSA-M 3-aminopropyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCN)C1=CC=CC=C1 UPYKKMDXNPTXPZ-UHFFFAOYSA-M 0.000 claims description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 238000000967 suction filtration Methods 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 5
- 238000001308 synthesis method Methods 0.000 claims description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 4
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 claims description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 4
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 4
- QFGMXJOBTNZHEL-UHFFFAOYSA-N isoxepac Chemical compound O1CC2=CC=CC=C2C(=O)C2=CC(CC(=O)O)=CC=C21 QFGMXJOBTNZHEL-UHFFFAOYSA-N 0.000 claims description 4
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 4
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 claims description 4
- 239000011736 potassium bicarbonate Substances 0.000 claims description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 235000011181 potassium carbonates Nutrition 0.000 claims description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 4
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 235000017550 sodium carbonate Nutrition 0.000 claims description 4
- 239000012312 sodium hydride Substances 0.000 claims description 4
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000002808 molecular sieve Substances 0.000 claims description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 3
- 229950011455 isoxepac Drugs 0.000 claims 3
- 239000007858 starting material Substances 0.000 claims 3
- 238000004090 dissolution Methods 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 abstract description 9
- 238000001914 filtration Methods 0.000 abstract description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- VQMJUHOJPCPUAM-IDUWFGFVSA-N N-Monodemethylolopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCNC)\C2=CC=CC=C21 VQMJUHOJPCPUAM-IDUWFGFVSA-N 0.000 description 38
- WCRQUKCFPDWETG-UHFFFAOYSA-N NCCCC(C=CC=C1)=C1P(C1=CC=CC=C1)C1=CC=CC=C1.Br Chemical compound NCCCC(C=CC=C1)=C1P(C1=CC=CC=C1)C1=CC=CC=C1.Br WCRQUKCFPDWETG-UHFFFAOYSA-N 0.000 description 17
- JARMQLAGTBFTAL-UHFFFAOYSA-N 3-bromo-n-methylpropan-1-amine;hydrobromide Chemical compound Br.CNCCCBr JARMQLAGTBFTAL-UHFFFAOYSA-N 0.000 description 10
- 238000001514 detection method Methods 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 238000012805 post-processing Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- POCGFRCQICXVJO-SOFYXZRVSA-N 2-[(11z)-11-(3-aminopropylidene)-6h-benzo[c][1]benzoxepin-2-yl]acetic acid Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN)\C2=CC=CC=C21 POCGFRCQICXVJO-SOFYXZRVSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000005292 vacuum distillation Methods 0.000 description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 3
- KTZXQICNJXRYEI-UHFFFAOYSA-M 3-(methylamino)propyl-triphenylphosphanium;bromide;hydrobromide Chemical compound Br.[Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCNC)C1=CC=CC=C1 KTZXQICNJXRYEI-UHFFFAOYSA-M 0.000 description 2
- HVRLZEKDTUEKQH-NOILCQHBSA-N Olopatadine hydrochloride Chemical compound Cl.C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 HVRLZEKDTUEKQH-NOILCQHBSA-N 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 229960003139 olopatadine hydrochloride Drugs 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- ZTGQZSKPSJUEBU-UHFFFAOYSA-N 3-bromopropan-1-amine Chemical compound NCCCBr ZTGQZSKPSJUEBU-UHFFFAOYSA-N 0.000 description 1
- LFYXVSMAWADPSX-UHFFFAOYSA-M 3-triphenylphosphaniumylpropylazanium;dibromide Chemical compound Br.[Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCN)C1=CC=CC=C1 LFYXVSMAWADPSX-UHFFFAOYSA-M 0.000 description 1
- MWWBWVZFQSFNJN-UHFFFAOYSA-N Br(=O)(=O)O.BrCCCNC Chemical compound Br(=O)(=O)O.BrCCCNC MWWBWVZFQSFNJN-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- REPWBKQJAMXHFL-UHFFFAOYSA-N phenylphosphane;hydrobromide Chemical compound [Br-].[PH3+]C1=CC=CC=C1 REPWBKQJAMXHFL-UHFFFAOYSA-N 0.000 description 1
- PMOIAJVKYNVHQE-UHFFFAOYSA-N phosphanium;bromide Chemical compound [PH4+].[Br-] PMOIAJVKYNVHQE-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 150000003512 tertiary amines Chemical group 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本申请涉及药物合成领域,主要涉及一种去甲基奥洛他定及其中间体的合成方法。The application relates to the field of pharmaceutical synthesis, and mainly relates to a method for synthesizing desmethyl olopatadine and an intermediate thereof.
背景技术Background technique
N-去甲基奥洛他定以及N,N-去二甲基奥洛他定通常用于标定新型H1受体拮抗剂盐酸奥洛他定中的杂质,以确定盐酸奥洛他定纯度。N-去甲基奥洛他定(N-DesMethylOlopatadine)化学名称:(Z)-11-[3-(甲氨基)亚丙基]-6,11-二氢二苯并[b,e]氧杂卓-2-乙酸,2-[(11Z)-11-[3-(methylamino)N-desmethyl olopatadine and N,N-desmethyl olopatadine are commonly used to demarcate the impurities in olopatadine hydrochloride, a novel H 1 receptor antagonist, to determine the purity of olopatadine hydrochloride . N-DesMethylOlopatadine (N-DesMethylOlopatadine) chemical name: (Z)-11-[3-(methylamino)propylene]-6,11-dihydrodibenzo[ b,e ]oxy Hetero-2-acetic acid, 2-[(11Z)-11-[3-(methylamino)
propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid,CAS:113835-92-0。N,N-去二甲基奥洛他定(N,N-Didesmethyl Olopatadine)化学名称:(Z)-11-[3-(氨基)亚丙基]-6,11-二氢二苯并[b,e]氧杂卓-2-乙酸,2-[(11Z)-11-[3-(amino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid,CAS:113835-94-2。N-去甲基奥洛他定、N,N-去二甲基奥洛他定以及奥洛他定结构式分别如下式所示:propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid, CAS: 113835-92-0. N,N-Didesmethyl Olopatadine (N,N-Didesmethyl Olopatadine) Chemical name: (Z)-11-[3-(amino)propylene]-6,11-dihydrodibenzo[ b,e ]oxazepin-2-acetic acid, 2-[(11Z)-11-[3-(amino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid, CAS: 113835-94-2. The structural formulas of N-desmethyl olopatadine, N,N-desmethyl olopatadine and olopatadine are as follows:
。 .
现获取N-去甲基奥洛他定和N,N-去二甲基奥洛他定方法较少,可通过参考奥洛他定合成方法,在合成过程中将含有叔胺结构的化合物替换成含有伯胺或仲胺结构的化合物,再按奥洛他定合成方法合成得目标产物。There are few methods to obtain N-desmethyl olopatadine and N,N-desmethyl olopatadine. By referring to the synthesis method of olopatadine, the compound containing tertiary amine structure can be replaced during the synthesis process into a compound containing a primary or secondary amine structure, and then according to the olopatadine synthesis method to synthesize the target product.
例如,EP0235796报道了以(3-溴丙基)三苯基溴化磷、甲胺、氨水为初始溶剂合成(3-甲氨基丙基)三苯基磷溴化物氢溴酸盐和(3-氨基丙基)三苯基磷溴化物氢溴酸盐,该两种氢溴酸盐与伊索克酸合成反式N-去甲基奥洛他定甲酯、N-去甲基奥洛他定甲酯、反式N,N-去二甲基奥洛他定甲酯和N,N-去二甲基奥洛他定甲酯,经柱层析得到N-去甲基奥洛他定甲酯和N,N-去二甲基奥洛他定甲酯。N-去甲基奥洛他定甲酯和N,N-去二甲基奥洛他定甲酯再水解得到N-去甲基奥洛他定和N,N-去二甲基奥洛他定。该合成方法中,合成过程需高温反应,涉及正丁基锂等危险化学品增大反应风险,反应步骤冗长导致整体收率严重降低。其合成路线如下式所示:For example, EP0235796 reported the synthesis of (3-methylaminopropyl) triphenylphosphonium bromide hydrobromide and (3- Aminopropyl) triphenylphosphonium bromide hydrobromide, the two kinds of hydrobromide and isokic acid synthesize trans-N-desmethyl olopatadine methyl ester, N-desmethyl olopatadine methyl ester, trans-N,N-desmethyl olopatadine methyl ester and N,N-desmethyl olopatadine methyl ester, N-desmethyl olopatadine obtained by column chromatography methyl ester and N,N-desdimethylolopatadine methyl ester. N-desmethyl olopatadine methyl ester and N,N-desmethyl olopatadine methyl ester are then hydrolyzed to obtain N-desmethyl olopatadine and N,N-desmethyl olopatadine Certainly. In the synthesis method, the synthesis process requires a high temperature reaction, involving dangerous chemicals such as n-butyllithium, which increases the reaction risk, and the lengthy reaction steps lead to a serious decrease in the overall yield. Its synthetic route is shown as follows:
。 .
因此,现有技术还有待于改进和发展。Therefore, the existing technology still needs to be improved and developed.
发明内容SUMMARY OF THE INVENTION
鉴于上述现有技术的不足,本申请的目的在于提供一种去甲基奥洛他定及其中间体的合成方法,旨在解决现有N-去甲基奥洛他定和N,N-去二甲基奥洛他定合成路线复杂、收率低的问题。In view of the deficiencies of the above-mentioned prior art, the purpose of this application is to provide a kind of synthetic method of desmethyl olopatadine and intermediate thereof, is intended to solve existing N-desmethyl olopatadine and N,N- The problems of complex synthetic route and low yield of dimethyl olopatadine are eliminated.
本申请的技术方案如下:The technical solution of this application is as follows:
一种去甲基奥洛他定的中间体的合成方法,其中,所述去甲基奥洛他定的中间体为(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦,包括以下步骤:A kind of synthetic method of the intermediate of desmethyl olopatadine, wherein, the intermediate of described desmethyl olopatadine is (3-methylaminopropyl) triphenylphosphine bromide or (3-amino propyl) triphenylphosphine bromide, comprising the following steps:
加入第一溶剂、三苯基膦和第一原料,在保护气体氛围下,加热搅拌;Add the first solvent, triphenylphosphine and the first raw material, and heat and stir under a protective gas atmosphere;
减压蒸馏至干,加水,加提取溶剂,分液保留有机相,有机相以中和碱溶液搅洗,分液保留有机相,有机相以干燥剂干燥后蒸馏至干;Distill under reduced pressure to dryness, add water, add extraction solvent, separate the organic phase to retain the organic phase, stir and wash the organic phase with a neutralized alkaline solution, separate the organic phase to retain the organic phase, and dry the organic phase with a desiccant and then distill to dryness;
加入重结晶溶剂,重结晶,抽滤得白色固体,将白色固体置于烘干至恒重;Add recrystallization solvent, recrystallization, suction filtration to obtain white solid, and the white solid is dried to constant weight;
所述第一原料为(3-溴丙基)(N-甲基)胺氢溴酸盐或3-溴丙胺氢溴酸盐;Described first raw material is (3-bromopropyl) (N-methyl) amine hydrobromide or 3-bromopropylamine hydrobromide;
当所述第一原料为所述(3-溴丙基)(N-甲基)胺氢溴酸盐时,制备得到的产物为(3-甲氨基丙基)三苯基溴化膦;当所述第一原料为所述3-溴丙胺氢溴酸盐时,制备得到的产物为(3-氨基丙基)三苯基溴化膦。When the first raw material is the (3-bromopropyl)(N-methyl)amine hydrobromide, the prepared product is (3-methylaminopropyl)triphenylphosphine bromide; when When the first raw material is the 3-bromopropylamine hydrobromide, the prepared product is (3-aminopropyl) triphenylphosphine bromide.
在本申请中,通过引入(3-溴丙基)(N-甲基)胺氢溴酸盐和3-溴丙胺氢溴酸盐分别与三苯基膦反应,再直接中和去除中间体的溴化氢分子,以便在后续N-去甲基奥洛他定和N,N-去二甲基奥洛他定合成中减少金属还原剂用量,达到高效却安全风险降低的目的。In this application, by introducing (3-bromopropyl) (N-methyl) amine hydrobromide and 3-bromopropylamine hydrobromide, respectively react with triphenylphosphine, and then directly neutralize and remove the intermediate Hydrogen bromide molecule, in order to reduce the amount of metal reducing agent in the subsequent synthesis of N-desmethyl olopatadine and N,N-desmethyl olopatadine, to achieve the purpose of high efficiency but reduced safety risk.
所述的去甲基奥洛他定的中间体的合成方法,其中,所述三苯基膦与所述(3-溴丙基)(N-甲基)胺氢溴酸盐摩尔比为1:(1.1~2.3);The synthetic method of the intermediate of described desmethyl olopatadine, wherein, the molar ratio of described triphenylphosphine and described (3-bromopropyl) (N-methyl) amine hydrobromide is 1 : (1.1~2.3);
所述三苯基膦与所述3-溴丙胺氢溴酸盐摩尔比为1:(1.1~2.4)。The molar ratio of the triphenylphosphine to the 3-bromopropylamine hydrobromide is 1: (1.1 to 2.4).
三苯基膦过多在后处理时候不利于除去未反应的三苯基膦,故三苯基膦相较于另一种核心原料的(3-溴丙基)(N-甲基)胺氢溴酸盐或3-溴丙胺氢溴酸盐要少。Too much triphenylphosphine is not conducive to removing unreacted triphenylphosphine during post-processing. Therefore, triphenylphosphine is compared to another core raw material (3-bromopropyl)(N-methyl)amine hydrogen Bromate or 3-bromopropylamine hydrobromide should be less.
所述的去甲基奥洛他定的中间体的合成方法,其中,所述保护气体为氩气或氮气;The synthetic method of the intermediate of described desmethyl olopatadine, wherein, described protective gas is argon or nitrogen;
所述第一溶剂为异丙醇、丙醇、混丙醇、乙腈、正丁醇、叔丁醇或异丁醇中的一种,所述第一溶剂与所述三苯基膦的质量比范围为(4~7):1;The first solvent is one of isopropanol, propanol, mixed propanol, acetonitrile, n-butanol, tert-butanol or isobutanol, and the mass ratio of the first solvent to the triphenylphosphine The range is (4~7): 1;
所述提取溶剂为二氯甲烷、三氯甲烷、四氯化碳、1,2-二氯乙烷、1,1-二氯乙烷、乙酸乙酯、甲苯或苯中的一种;所述水与所述三苯基膦的质量比范围为(5~7):1,所述提取溶剂与所述三苯基膦的质量比范围为(10~15):1;The extraction solvent is one of dichloromethane, trichloromethane, carbon tetrachloride, 1,2-dichloroethane, 1,1-dichloroethane, ethyl acetate, toluene or benzene; the The mass ratio range of water to the triphenylphosphine is (5~7):1, and the mass ratio range of the extraction solvent to the triphenylphosphine is (10~15):1;
所述中和碱为氢氧化钠、氢氧化钾、碳酸钠、碳酸氢钠、碳酸钾、碳酸氢钾、氨水、二乙胺或三乙胺中的一种;所述中和碱溶液的质量浓度范围为10%~30%,所述中和碱溶液中中和碱含量与所述三苯基膦的质量比范围为(0.2~0.6):1;Described neutralization alkali is a kind of in sodium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, ammoniacal liquor, diethylamine or triethylamine; The quality of described neutralization alkali solution The concentration range is 10% to 30%, and the mass ratio of the content of the neutralized alkali in the neutralized alkali solution to the triphenylphosphine is in the range of (0.2 to 0.6): 1;
所述干燥剂为无水硫酸钠、无水硫酸镁或分子筛中的一种,所述干燥剂与三苯基膦的质量比范围为(0.5~1):1;The desiccant is one of anhydrous sodium sulfate, anhydrous magnesium sulfate or molecular sieve, and the mass ratio of the desiccant to triphenylphosphine ranges from (0.5 to 1): 1;
所述重结晶溶剂为四氢呋喃、二氧六环、乙腈、乙酸乙酯或乙醚中的一种;所述重结晶溶剂与所述三苯基膦的质量比范围为(1~2):1。The recrystallization solvent is one of tetrahydrofuran, dioxane, acetonitrile, ethyl acetate or diethyl ether; the mass ratio of the recrystallization solvent to the triphenylphosphine ranges from (1 to 2):1.
所述的去甲基奥洛他定的中间体的合成方法,其中,所述第一溶剂为异丙醇;The synthetic method of the intermediate of described desmethyl olopatadine, wherein, the first solvent is isopropanol;
所述提取溶剂为二氯甲烷;The extraction solvent is dichloromethane;
所述中和碱为氢氧化钠;Described neutralization alkali is sodium hydroxide;
所述干燥剂为无水硫酸钠;Described desiccant is anhydrous sodium sulfate;
所述重结晶溶剂为四氢呋喃。The recrystallization solvent is tetrahydrofuran.
所述的去甲基奥洛他定的中间体的合成方法,其中,所述加热搅拌的过程具体为加热至75~82℃搅拌10~16小时;The synthetic method of the described intermediate of desmethyloclopatadine, wherein, the process of heating and stirring is specifically heated to 75~82° C. and stirred for 10~16 hours;
所述重结晶的过程为升温至物料溶解的温度范围,所述物料溶解的温度范围为60~66℃,再降温至物料结晶的温度范围,所述物料结晶的温度范围为-5~5℃;The process of described recrystallization is warming up to the temperature range of material dissolving, the temperature range of described material dissolving is 60~66 ℃, and then cooling down to the temperature range of material crystallization, the temperature range of described material crystallization is-5~5 ℃ ;
所述烘干的过程中温度控制在55~65℃。During the drying process, the temperature is controlled at 55-65°C.
一种去甲基奥洛他定的合成方法,去甲基奥洛他定为N-去甲基奥洛他定或N,N-去二甲基奥洛他定,其中,包括以下步骤:A kind of synthetic method of desmethyl olopatadine, desmethyl olopatadine is N-desmethyl olopatadine or N,N-desmethyl olopatadine, wherein, comprises the following steps:
采用如上所述的去甲基奥洛他定的中间体的合成方法制备第二原料,所述第二原料为(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦;Adopt the above-mentioned synthetic method of the intermediate of desmethyl olopatadine to prepare the second raw material, and the second raw material is (3-methylaminopropyl) triphenylphosphine bromide or (3-aminopropyl) ) triphenylphosphine bromide;
加入所述第二原料和第二溶剂,开启搅拌,控温,加入金属还原剂,加完后控温,反应若干小时;Add the second raw material and the second solvent, start stirring, control the temperature, add a metal reducing agent, control the temperature after adding, and react for several hours;
加入伊索克酸,控温搅拌若干小时,再降温,加入第一淬灭溶剂,再加入第二淬灭溶剂,最后加入水淬灭反应;Add isoxocic acid, control the temperature and stir for several hours, then lower the temperature, add the first quenching solvent, then add the second quenching solvent, and finally add water to quench the reaction;
加入酸调节pH值,减压蒸馏至干,干品经柱层析分离;Add acid to adjust pH value, distill to dryness under reduced pressure, and separate the dry product by column chromatography;
当所述第二原料为(3-甲氨基丙基)三苯基溴化膦时,制备得到的产物为N-去甲基奥洛他定;当所述第二原料为(3-氨基丙基)三苯基溴化膦时,制备得到的产物为N,N-去二甲基奥洛他定。When the second raw material is (3-methylaminopropyl) triphenylphosphine bromide, the prepared product is N-desmethyl olopatadine; when the second raw material is (3-aminopropyl) base) triphenylphosphine bromide, the prepared product is N,N-desdimethylolopatadine.
所述的去甲基奥洛他定的合成方法,其中,所述第二原料与所述伊索克酸质量比范围为(1.5~2.5):1;The synthetic method of the described desmethyl olopatadine, wherein, the mass ratio range of the second raw material to the isoxocic acid is (1.5-2.5): 1;
当所述第二原料为(3-甲氨基丙基)三苯基溴化膦时,所述调节pH值为调节pH值至7.2~7.8;当所述第二原料为(3-氨基丙基)三苯基溴化膦时,所述调节pH值为调节pH值至8.0~8.4。When the second raw material is (3-methylaminopropyl) triphenylphosphine bromide, the pH value is adjusted to 7.2~7.8; when the second raw material is (3-aminopropyl) ) triphenylphosphine bromide, the pH value is adjusted to 8.0~8.4.
所述的去甲基奥洛他定的合成方法,其中,所述第二溶剂为四氢呋喃、氯仿或甲苯中的一种,所述溶剂与所述伊索克酸的质量比范围为(5~15):1;The synthetic method of described desmethyl olopatadine, wherein, described second solvent is a kind of in tetrahydrofuran, chloroform or toluene, and the mass ratio scope of described solvent and described isoxocic acid is (5~5~1. 15): 1;
所述金属还原剂为氢化钾、氢化钠、氢化钙、正丁基锂、叔丁基锂或氢化锂铝中的一种,所述金属还原剂的质量浓度范围为30%~35%,所述金属还原剂中所述金属还原剂的含量与所述伊索克酸质量比范围为(0.4~0.8):1;The metal reducing agent is one of potassium hydride, sodium hydride, calcium hydride, n-butyl lithium, tert-butyl lithium or lithium aluminum hydride, and the mass concentration range of the metal reducing agent is 30% to 35%. The content of the metal reducing agent in the metal reducing agent and the isokic acid mass ratio range is (0.4~0.8): 1;
所述第一淬灭溶剂为无水甲醇或无水乙醇,所述第一淬灭溶剂与所述伊索克酸质量比范围为(0.2~0.4):1,所述第二淬灭溶剂为四氢呋喃水溶液,所述四氢呋喃水溶液的质量浓度为40~60%,所述四氢呋喃水溶液中所述四氢呋喃的含量与所述伊索克酸质量比范围为(1.5~2.5):1;所述水与所述伊索克酸的质量比范围为(10~20):1;The first quenching solvent is anhydrous methanol or anhydrous ethanol, the mass ratio of the first quenching solvent to the isokic acid is (0.2~0.4): 1, and the second quenching solvent is Tetrahydrofuran aqueous solution, the mass concentration of the tetrahydrofuran aqueous solution is 40~60%, and the content of the tetrahydrofuran in the tetrahydrofuran aqueous solution and the isoxic acid mass ratio range is (1.5~2.5): 1; The mass ratio range of isoxocic acid is (10~20): 1;
所述酸为盐酸、硫酸或醋酸中的一种;Described acid is a kind of in hydrochloric acid, sulfuric acid or acetic acid;
所述柱层析分离过程中,洗脱剂为乙酸乙酯与甲醇体系、乙酸乙酯与乙醇体系或乙酸乙酯与丙酮体系,层析柱中的填料为硅胶和碱性氧化铝。During the separation process of the column chromatography, the eluent is a system of ethyl acetate and methanol, a system of ethyl acetate and ethanol, or a system of ethyl acetate and acetone, and the fillers in the chromatography column are silica gel and basic alumina.
所述的去甲基奥洛他定的合成方法,其中,所述第二溶剂为四氢呋喃;The synthetic method of described desmethyl olopatadine, wherein, the second solvent is tetrahydrofuran;
所述金属还原剂为氢化钾;Described metal reducing agent is potassium hydride;
所述第一淬灭溶剂为无水甲醇;The first quenching solvent is anhydrous methanol;
所述酸为浓盐酸,所述浓盐酸的质量浓度为20%~38%;Described acid is concentrated hydrochloric acid, and the mass concentration of described concentrated hydrochloric acid is 20%~38%;
所述洗脱剂为乙酸乙酯与甲醇体系,所述乙酸乙酯与所述甲醇比例为(6~10):1。The eluent is an ethyl acetate and methanol system, and the ratio of the ethyl acetate to the methanol is (6-10):1.
所述的去甲基奥洛他定的合成方法,其中,所述控温,加入金属还原剂的过程具体为控温在18~25℃,加入金属还原剂;The method for synthesizing desmethyl olopatadine, wherein, the temperature control, the process of adding a metal reducing agent is specifically controlling the temperature at 18-25° C., adding a metal reducing agent;
所述加完后控温,反应若干小时的过程具体为加完后控温在58~66℃,反应1~2小时;The described temperature control after adding, and the process of reacting for several hours is specifically that the temperature is controlled at 58~66 ℃ after adding, and the reaction is performed for 1~2 hours;
所述加入伊索克酸,控温搅拌若干小时,再降温的过程具体为加入伊索克酸,控温在58~66℃搅拌1.5~3.5小时,再降温至5~10℃。The process of adding isoxocic acid, controlling the temperature and stirring for several hours, and then cooling down is specifically adding isoxocic acid, stirring at 58-66° C. for 1.5-3.5 hours under temperature control, and then cooling to 5-10° C.
有益效果:本申请所提供的去甲基奥洛他定的合成方法,在现有技术的基础上,对关键步骤进行了升级改造,具有以下优点:1、中间体去除不必要分子,降低下一步反应风险性;2、减少了反应步骤,降低损耗,提高了生产效率;3、替换金属还原剂,降低反应以及后处理风险;4、后处理简洁、直接分离;5、反应条件温和,对设备要求不高;6、收率高,质量好。Beneficial effect: the synthetic method of desmethyl olopatadine provided by the application, on the basis of the prior art, has carried out upgrading and transformation to the key steps, has the following advantages: 1, the intermediate removes unnecessary molecules, reduces the lower One-step reaction risk; 2. Reduce reaction steps, reduce loss, and improve production efficiency; 3. Replace metal reducing agent, reduce reaction and post-processing risks; 4. Post-processing is concise and direct separation; 5. The reaction conditions are mild, and the The equipment requirements are not high; 6. The yield is high and the quality is good.
附图说明Description of drawings
图1为本申请实施例1中所得产品N-去甲基奥洛他定的HPLC检测结果图。Fig. 1 is the HPLC detection result figure of the product N-desmethylolopatadine obtained in Example 1 of the application.
图2为本申请实施例2中所得产品N,N-去二甲基奥洛他定的HPLC检测结果图。Fig. 2 is the HPLC detection result diagram of the product obtained in the embodiment 2 of the application, N,N-desdimethyloclopatadine.
图3为本申请实施例3中所得产品N-去甲基奥洛他定的HPLC检测结果图。Fig. 3 is the HPLC detection result diagram of the product obtained in Example 3 of the application, N-desmethylolopatadine.
图4为本申请实施例4中所得产品N,N-去二甲基奥洛他定的HPLC检测结果图。Fig. 4 is the HPLC detection result figure of the product obtained in the embodiment 4 of the application, N,N-desdimethylolopatadine.
具体实施方式Detailed ways
本申请提供一种去甲基奥洛他定的合成方法及其中间体的合成方法,为使本申请的目的、技术方案及效果更加清楚、明确,以下对本申请进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本申请,并不用于限定本申请。The present application provides a synthetic method of desmethyl olopatadine and a synthetic method of its intermediates. In order to make the purpose, technical scheme and effect of the present application more clear and definite, the present application is further described in detail below. It should be understood that the specific embodiments described herein are only used to explain the present application, but not to limit the present application.
在本申请中,去甲基奥洛他定的中间体为(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦,去甲基奥洛他定为N-去甲基奥洛他定或N,N-去二甲基奥洛他定。In this application, the intermediate of desmethylolopatadine is (3-methylaminopropyl) triphenylphosphine bromide or (3-aminopropyl) triphenylphosphine bromide, and desmethylolopatadine He was designated as N-desmethyl olopatadine or N,N-desmethyl olopatadine.
本申请中,涉及的化合物包括:三苯基膦(CAS:603-35-0)、(3-溴丙基)(N-甲基)胺氢溴酸盐(CAS:60035-88-3)、3-溴丙胺氢溴酸盐(CAS:5003-71-4)、(3-甲氨基丙基)三苯基溴化膦(CAS:145126-87-0)、(3-氨基丙基)三苯基溴化膦(CAS:89996-01-0)和伊索克酸(CAS:55453-87-7),各分子结构式如下:In this application, the compounds involved include: triphenylphosphine (CAS:603-35-0), (3-bromopropyl)(N-methyl)amine hydrobromide (CAS:60035-88-3) , 3-bromopropylamine hydrobromide (CAS: 5003-71-4), (3-methylaminopropyl) triphenylphosphine bromide (CAS: 145126-87-0), (3-aminopropyl) Triphenylphosphine bromide (CAS: 89996-01-0) and isokic acid (CAS: 55453-87-7), the molecular structures are as follows:
。 .
本申请提供一种去甲基奥洛他定的中间体的合成方法,通过引入(3-溴丙基)(N-甲基)胺氢溴酸盐和3-溴丙胺氢溴酸盐分别与三苯基膦反应,再直接中和去除中间体的溴化氢分子,以便在后续N-去甲基奥洛他定和N,N-去二甲基奥洛他定合成中减少金属还原剂用量,达到高效却安全风险降低的目的。The application provides a kind of synthetic method of the intermediate of desmethyl olopatadine, by introducing (3-bromopropyl) (N-methyl) amine hydrobromide and 3-bromopropylamine hydrobromide respectively with Triphenylphosphine reaction, and then directly neutralize and remove the hydrogen bromide molecule of the intermediate, so as to reduce the metal reducing agent in the subsequent synthesis of N-desmethyl olopatadine and N,N-desmethyl olopatadine Dosage to achieve high efficiency but reduce safety risks.
具体地,去甲基奥洛他定的中间体的合成方法,去甲基奥洛他定的中间体为(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦,包括以下步骤:Specifically, the synthetic method of the intermediate of desmethyl olopatadine, the intermediate of desmethyl olopatadine is (3-methylaminopropyl) triphenylphosphine bromide or (3-aminopropyl) Triphenylphosphine bromide, comprising the following steps:
加入第一溶剂,三苯基膦和第一原料,在保护气体氛围下,加热搅拌;Add the first solvent, triphenylphosphine and the first raw material, and heat and stir under a protective gas atmosphere;
减压蒸馏至干,加水,加提取溶剂,分液保留有机相,有机相以中和碱溶液搅洗,分液保留有机相,有机相以干燥剂干燥后蒸馏至干;Distill under reduced pressure to dryness, add water, add extraction solvent, separate the organic phase to retain the organic phase, stir and wash the organic phase with a neutralized alkaline solution, separate the organic phase to retain the organic phase, and dry the organic phase with a desiccant and then distill to dryness;
加入重结晶溶剂,重结晶,抽滤得白色固体,将白色固体置于烘干至恒重,得(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦。Add a recrystallization solvent, recrystallize, and suction filtration to obtain a white solid, which is dried to constant weight to obtain (3-methylaminopropyl)triphenylphosphine bromide or (3-aminopropyl)triphenylene Phosphine bromide.
第一原料为(3-溴丙基)(N-甲基)胺氢溴酸盐或3-溴丙胺氢溴酸盐。当第一原料为(3-溴丙基)(N-甲基)胺氢溴酸盐时,制备得到的产物为(3-甲氨基丙基)三苯基溴化膦;当第一原料为3-溴丙胺氢溴酸盐时,制备得到的产物为(3-氨基丙基)三苯基溴化膦。The first raw material is (3-bromopropyl) (N-methyl)amine hydrobromide or 3-bromopropylamine hydrobromide. When the first raw material is (3-bromopropyl)(N-methyl)amine hydrobromide, the prepared product is (3-methylaminopropyl)triphenylphosphine bromide; when the first raw material is When 3-bromopropylamine hydrobromide is used, the prepared product is (3-aminopropyl) triphenylphosphine bromide.
三苯基膦作为化学反应核心原料,参与化学结构搭建,且三苯基膦过多在后处理时候不利于除去未反应的三苯基膦,故三苯基膦相较于另一种核心原料的(3-溴丙基)(N-甲基)胺氢溴酸盐或3-溴丙胺氢溴酸盐要少。因此,在本申请中,三苯基膦与(3-溴丙基)(N-甲基)胺氢溴酸盐摩尔比为1:(1.1~2.3);三苯基膦与3-溴丙胺氢溴酸盐摩尔比为1:(1.1~2.4)。As the core raw material of chemical reaction, triphenylphosphine participates in the construction of chemical structure, and too much triphenylphosphine is not conducive to removing unreacted triphenylphosphine during post-processing. Therefore, triphenylphosphine is compared with another core raw material. (3-bromopropyl)(N-methyl)amine hydrobromide or 3-bromopropylamine hydrobromide is less. Therefore, in this application, the molar ratio of triphenylphosphine to (3-bromopropyl)(N-methyl)amine hydrobromide is 1:(1.1~2.3); triphenylphosphine to 3-bromopropylamine The molar ratio of hydrobromide is 1:(1.1~2.4).
第一溶剂可以为异丙醇、丙醇、混丙醇、乙腈、正丁醇、叔丁醇或异丁醇中的一种,第一溶剂与三苯基膦的质量比范围可以为(4~7):1。在本申请实施例方案中,以异丙醇作为第一溶剂,能达到反应所需的温度且溶解两种产品,若换成其它替代溶剂也能达到同样效果,只是反应时间长短问题,其它可替代溶剂为正丙醇、混丙醇、乙腈、正丁醇、叔丁醇和异丁醇。The first solvent can be a kind of in isopropanol, propanol, mixed propanol, acetonitrile, n-butanol, tert-butanol or isobutanol, and the mass ratio scope of the first solvent and triphenylphosphine can be (4 ~7): 1. In the embodiment of the present application, using isopropanol as the first solvent can reach the temperature required for the reaction and dissolve the two products. If it is replaced with other alternative solvents, the same effect can also be achieved, but the reaction time is only a matter of time. Alternative solvents are n-propanol, mixed propanol, acetonitrile, n-butanol, tert-butanol and isobutanol.
保护气体可以为氩气或氮气。加热搅拌的过程具体为加热至75~82℃搅拌10~16小时。The shielding gas can be argon or nitrogen. The process of heating and stirring is specifically heating to 75-82° C. and stirring for 10-16 hours.
在本申请实施例方案中,第一溶剂与后续提取溶剂有一定互溶性,故选择蒸馏至干去除第一溶剂,再进行萃取。蒸馏干后,选择以水溶解再以提取溶剂萃取,而不是直接以提取溶剂取过滤,因为两相都为液相能更完全萃取出产品提高收率,在实际生产中有机相和水相分液相较于过滤更简单,提取溶剂不溶解的固体也很有可能形成大片固体在实际生产中并不利于从生产釜底阀放出过滤,未反应的原料(3-溴丙基)(N-甲基)胺氢溴酸盐或3-溴丙胺氢溴酸盐若在无水条件下也能溶解部分在二氯甲烷中作为杂质一直存在。In the embodiments of the present application, the first solvent and the subsequent extraction solvent have a certain mutual solubility, so the first solvent is selected to be distilled to dryness to remove the first solvent, and then the extraction is performed. After distillation, choose to dissolve in water and then extract with the extraction solvent, instead of directly using the extraction solvent for filtration, because both phases are liquid phases, which can more completely extract the product and improve the yield. In actual production, the organic phase and the water phase are separated. The liquid is simpler than filtration, and the undissolved solid of the extraction solvent is also likely to form large pieces of solid. In actual production, it is not conducive to discharge and filter from the bottom valve of the production kettle. The unreacted raw material (3-bromopropyl) (N- Methyl)amine hydrobromide or 3-bromopropylamine hydrobromide can also be dissolved under anhydrous conditions and part of it exists as an impurity in dichloromethane.
提取溶剂可以为二氯甲烷、三氯甲烷、四氯化碳、1,2-二氯乙烷、1,1-二氯乙烷、乙酸乙酯、甲苯或苯中的一种。减压蒸馏至干后,水的加入量与三苯基膦的质量比范围可以为(5~7):1,提取溶剂的加入量与三苯基膦的质量比范围可以为(10~15):1。在本申请实施例方案中,选取二氯甲烷作为提取溶剂,因为其与产品互溶性强,毒性低,价格低廉,沸点低容易蒸馏,与水不互溶好分液。其它可替代的提取溶剂可以为三氯甲烷、四氯化碳、1,2-二氯乙烷、1,1-二氯乙烷、乙酸乙酯、甲苯或苯。The extraction solvent can be one of dichloromethane, trichloromethane, carbon tetrachloride, 1,2-dichloroethane, 1,1-dichloroethane, ethyl acetate, toluene or benzene. After distillation under reduced pressure to dryness, the range of the mass ratio of the added amount of water to triphenylphosphine can be (5~7): 1, and the range of the added amount of the extraction solvent to the mass ratio of triphenylphosphine can be (10~15). ):1. In the embodiments of the present application, dichloromethane is selected as the extraction solvent, because it has strong mutual solubility with the product, low toxicity, low price, low boiling point and easy distillation, and is immiscible with water and good for liquid separation. Other alternative extraction solvents may be chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1-dichloroethane, ethyl acetate, toluene or benzene.
中和碱可以为氢氧化钠、氢氧化钾、碳酸钠、碳酸氢钠、碳酸钾、碳酸氢钾、氨水、二乙胺或三乙胺中的一种。在此步骤中,中和碱溶液的质量浓度范围可以为10%~30%,中和碱溶液中中和碱含量与三苯基膦的质量比范围可以为(0.2~0.6):1。在本申请实施例方案中,有机相选取氢氧化钠溶液作为中和碱溶液进行搅洗,其主要目的是去除(3-甲氨基丙基)三苯基溴化膦氢溴酸盐或(3-氨基丙基)三苯基溴化膦氢溴酸盐中的氢溴酸分子,以得到游离状态的产品(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦,与此同时氢氧化钠方便易得还价格低廉利于工业生产。除氢氧化钠溶液外,中和碱溶液还可以为氢氧化钾、碳酸钠、碳酸氢钠、碳酸钾、碳酸氢钾、氨水、二乙胺或三乙胺配制的溶液,这些溶液也具有同样效果。The neutralizing base can be one of sodium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, ammonia water, diethylamine or triethylamine. In this step, the mass concentration range of the neutralized alkali solution can be 10%-30%, and the mass ratio of the neutralized alkali content to triphenylphosphine in the neutralized alkali solution can be (0.2-0.6):1. In the embodiment of the present application, the organic phase selects sodium hydroxide solution as the neutralized alkali solution to stir and wash, and its main purpose is to remove (3-methylaminopropyl) triphenylphosphonium bromide hydrobromide or (3 -aminopropyl) triphenylphosphine bromide hydrobromide molecule in hydrobromide to obtain the free state product (3-methylaminopropyl) triphenylphosphine bromide or (3-aminopropyl) Triphenylphosphine bromide, and at the same time, sodium hydroxide is convenient and easy to obtain and low in price, which is beneficial to industrial production. In addition to sodium hydroxide solution, the neutralized alkali solution can also be a solution prepared by potassium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, ammonia water, diethylamine or triethylamine, and these solutions also have the same Effect.
有机相以干燥剂干燥的过程中,干燥剂可以为无水硫酸钠、无水硫酸镁或分子筛中的一种,干燥剂的加入量与三苯基膦的质量比范围可以为(0.5~1):1。In the process of drying the organic phase with a desiccant, the desiccant can be one of anhydrous sodium sulfate, anhydrous magnesium sulfate or molecular sieve, and the amount of the desiccant added to the mass ratio of triphenylphosphine can range from (0.5 to 1 ):1.
有机相以干燥剂干燥后蒸馏至干后,以重结晶溶剂进行重结晶能有效溶解产品再降温析出产品,且能很好去除杂质达到提纯目的。重结晶溶剂可以为四氢呋喃、二氧六环、乙腈、乙酸乙酯或乙醚中的一种。重结晶的过程为升温再降温,升温至物料溶解的温度范围60~66℃,降温至物料结晶的温度范围-5~5℃。重结晶溶剂的加入量与三苯基膦的质量比范围可以为(1~2):1。本申请实施例方案中,重结晶溶剂为四氢呋喃,可替换溶剂为二氧六环、乙腈、乙酸乙酯或乙醚。The organic phase is dried with a desiccant, distilled to dryness, and then recrystallized with a recrystallization solvent, which can effectively dissolve the product and then cool down to separate the product, and can well remove impurities to achieve the purpose of purification. The recrystallization solvent can be one of tetrahydrofuran, dioxane, acetonitrile, ethyl acetate or diethyl ether. The process of recrystallization is to heat up and then cool down, heat up to the temperature range of 60~66°C where the material dissolves, and cool down to the temperature range of -5~5°C for the material to crystallize. The range of the added amount of the recrystallization solvent to the mass ratio of triphenylphosphine can be (1~2):1. In the embodiments of the present application, the recrystallization solvent is tetrahydrofuran, and the alternative solvent is dioxane, acetonitrile, ethyl acetate or diethyl ether.
烘干的过程中温度控制在55~65℃,可以使用热风循环烘箱、真空烘箱、双锥干燥机或沸腾床。During the drying process, the temperature is controlled at 55~65℃, and hot air circulation oven, vacuum oven, double cone dryer or fluidized bed can be used.
本申请中还提供一种去甲基奥洛他定的合成方法,去甲基奥洛他定为N-去甲基奥洛他定或N,N-去二甲基奥洛他定,其中采用上述合成方法合成得到的去甲基奥洛他定的中间体为第二原料,可以减少金属还原剂用量,同时,在后续后处理中直接分离异构体得到目标产物,舍弃成酯分离再水解步骤,减少反应步骤,简化去甲基奥洛他定的合成路线,提高收率。The present application also provides a synthetic method of desmethyl olopatadine, and desmethyl olopatadine is N-desmethyl olopatadine or N,N-desmethyl olopatadine, wherein The intermediate of desmethyl olopatadine synthesized by the above synthesis method is the second raw material, which can reduce the amount of metal reducing agent. At the same time, in the subsequent post-processing, the isomers are directly separated to obtain the target product, and the ester separation is discarded. The hydrolysis step is reduced, the reaction step is reduced, the synthetic route of desmethyloclopatadine is simplified, and the yield is improved.
具体地,去甲基奥洛他定的合成方法,包括以下步骤:Specifically, the synthetic method of desmethyl olopatadine, comprises the following steps:
加入第二原料和第二溶剂,开启搅拌,控温在18~25℃,加入金属还原剂,加完后控温在58~66℃,反应1~2小时;Add the second raw material and the second solvent, start stirring, control the temperature at 18-25°C, add a metal reducing agent, control the temperature at 58-66°C after adding, and react for 1-2 hours;
加入伊索克酸,控温在58~66℃搅拌1.5~3.5小时,再降温至5~10℃,缓慢加入第一淬灭溶剂,再加入第二淬灭溶剂,最后加入水淬灭反应;Add isokic acid, control the temperature at 58-66 °C and stir for 1.5-3.5 hours, then cool down to 5-10 °C, slowly add the first quenching solvent, then add the second quenching solvent, and finally add water to quench the reaction;
反应液以酸调节pH,然后减压蒸馏至干,干品经柱层析分离,得成品N-去甲基奥洛他定或N,N-去二甲基奥洛他定。The pH of the reaction solution is adjusted with acid, and then distilled under reduced pressure to dryness, and the dry product is separated by column chromatography to obtain the finished product N-desmethylolopatadine or N,N-desmethylolopatadine.
第二原料为(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦,第二原料与伊索克酸质量比范围为(1.5~2.5):1。当第二原料为(3-甲氨基丙基)三苯基溴化膦时,制备得到的产物为N-去甲基奥洛他定;当第二原料为(3-氨基丙基)三苯基溴化膦时,制备得到的产物为N,N-去二甲基奥洛他定。(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦为均匀游离碱,这样可以有效减少金属还原剂使用量,可降低生产风险。第二原料为合成成品的的核心原料,参与产品结构构建,无其他可替代原料。The second raw material is (3-methylaminopropyl) triphenylphosphine bromide or (3-aminopropyl) triphenylphosphine bromide, and the mass ratio of the second raw material to isokic acid is in the range of (1.5~2.5) :1. When the second raw material is (3-methylaminopropyl) triphenylphosphine bromide, the prepared product is N-desmethyl olopatadine; when the second raw material is (3-aminopropyl) triphenyl bromide When phosphine bromide is used, the prepared product is N,N-desdimethylolopatadine. (3-Methylaminopropyl)triphenylphosphine bromide or (3-aminopropyl)triphenylphosphine bromide is a uniform free base, which can effectively reduce the amount of metal reducing agent used, and can reduce production risks. The second raw material is the core raw material of the synthetic finished product, which participates in the construction of the product structure, and there is no other alternative raw material.
伊索克酸为合成成品的核心原料,参与产品结构构建。虽然可以伊索克酸甲酯可替代伊索克酸使用,但反应完还得水解成产品,增多反应步骤减少收率。因此,在本申请中,选用伊索克酸作为核心原料之一。Isokic acid is the core raw material for synthetic finished products and participates in the construction of product structure. Although methyl isoxocate can be used instead of isoxocic acid, it has to be hydrolyzed into a product after the reaction, and the number of reaction steps is increased to reduce the yield. Therefore, in this application, isoxocic acid is selected as one of the core raw materials.
第二溶剂可以为四氢呋喃、氯仿或甲苯中的一种,第二溶剂与伊索克酸的质量比范围为(5~15):1。本申请实施例方案中,选用四氢呋喃作为第二溶剂,能达到反应所需的温度且溶解两种产品,若换成其它替代溶剂也能达到同样效果,只是反应时间长短问题。其它可替代溶剂为氯仿或甲苯。The second solvent can be one of tetrahydrofuran, chloroform or toluene, and the mass ratio of the second solvent to isokic acid is in the range of (5-15):1. In the embodiment scheme of the present application, tetrahydrofuran is selected as the second solvent, which can reach the temperature required for the reaction and dissolve the two products. If it is replaced with other alternative solvents, the same effect can be achieved, but the reaction time is a problem. Other alternative solvents are chloroform or toluene.
金属还原剂可以为氢化钾、氢化钠、氢化钙、正丁基锂、叔丁基锂或氢化锂铝中的一种,金属还原剂的质量浓度范围可以为30%~35%,金属还原剂中金属还原剂的含量与伊索克酸质量比范围为(0.4~0.8):1。在本申请实施例方案中,选用氢化钾为金属还原剂,可有效拔出伊索克酸中酮羰基的氧原子使其活化,与此同时也能拔出(3-甲氨基丙基)三苯基溴化膦或(3-氨基丙基)三苯基溴化膦中的溴原子达到活化目的,促进反应。氢化钾较其它金属还原剂温和,能降低生产风险有利于工业化。若不考虑合成效率和安全性,其可替代为氢化钠、氢化钙、正丁基锂、叔丁基锂或氢化锂铝。The metal reducing agent can be one of potassium hydride, sodium hydride, calcium hydride, n-butyl lithium, tert-butyl lithium or lithium aluminum hydride, and the mass concentration range of the metal reducing agent can be 30% to 35%. The ratio of the content of the metal reducing agent to the mass of isokic acid is in the range of (0.4~0.8):1. In the embodiment scheme of this application, potassium hydride is selected as the metal reducing agent, which can effectively pull out the oxygen atom of the ketone carbonyl group in isokic acid to activate it, and at the same time, it can also pull out (3-methylaminopropyl) three The bromine atom in phenylphosphine bromide or (3-aminopropyl) triphenylphosphine bromide achieves the purpose of activation and promotes the reaction. Potassium hydride is milder than other metal reducing agents, which can reduce production risks and is beneficial to industrialization. If synthesis efficiency and safety are not considered, it can be replaced by sodium hydride, calcium hydride, n-butyllithium, tert-butyllithium or lithium aluminum hydride.
在本申请中,第一淬灭溶剂为无水甲醇或无水乙醇,第一淬灭溶剂与伊索克酸质量比范围为(0.2~0.4):1,第二淬灭溶剂为四氢呋喃水溶液,四氢呋喃水溶液的质量浓度为40~60%,四氢呋喃水溶液中四氢呋喃的含量与伊索克酸质量比范围为(1.5~2.5):1。在本申请实施例方案中,选取无水甲醇和四氢呋喃水溶液组合作为淬灭溶剂,是因为淬灭通常为甲醇或水,而水与体系中未反应的氢化钾直接反应更剧烈,因而在本申请中选取无水甲醇和四氢呋喃的水溶液循序渐进式淬灭,从而降低安全风险也能有效控制温度提高淬灭效率。In this application, the first quenching solvent is anhydrous methanol or anhydrous ethanol, the mass ratio of the first quenching solvent to isokic acid is (0.2~0.4): 1, and the second quenching solvent is an aqueous solution of tetrahydrofuran, The mass concentration of the tetrahydrofuran aqueous solution is 40-60%, and the ratio of the content of tetrahydrofuran in the tetrahydrofuran aqueous solution to the mass ratio of isokic acid is (1.5-2.5):1. In the embodiment scheme of the present application, the combination of anhydrous methanol and tetrahydrofuran aqueous solution is selected as the quenching solvent, because the quenching is usually methanol or water, and the direct reaction between water and unreacted potassium hydride in the system is more violent, so in the present application The aqueous solution of anhydrous methanol and tetrahydrofuran is selected for quenching step by step, thereby reducing the safety risk and effectively controlling the temperature to improve the quenching efficiency.
在本申请中,最后加入水淬灭反应过程中,水与伊索克酸的质量比范围为(10~20):1。In the present application, during the final addition of water to quench the reaction process, the mass ratio of water to isokic acid is in the range of (10-20):1.
在本申请中,酸可以为盐酸、硫酸或醋酸中的一种。本申请实施例方案中,选用浓盐酸调pH,浓盐酸的质量浓度为20%~38%,因为浓盐酸较其它酸类便宜且常用,盐酸、硫酸或醋酸也可以作为替代品。当第二原料为(3-甲氨基丙基)三苯基溴化膦时,调节pH至7.2~7.8;当第二原料为(3-氨基丙基)三苯基溴化膦时,调节pH至8.0~8.4。In this application, the acid may be one of hydrochloric acid, sulfuric acid or acetic acid. In the embodiment scheme of the present application, concentrated hydrochloric acid is selected to adjust pH, and the mass concentration of concentrated hydrochloric acid is 20% to 38%. Because concentrated hydrochloric acid is cheaper and commonly used than other acids, hydrochloric acid, sulfuric acid or acetic acid can also be used as substitutes. When the second raw material is (3-methylaminopropyl)triphenylphosphine bromide, adjust the pH to 7.2~7.8; when the second raw material is (3-aminopropyl)triphenylphosphine bromide, adjust the pH to 8.0~8.4.
在本申请中,柱层析分离过程中所采用的洗脱剂可以为乙酸乙酯与甲醇体系、乙酸乙酯与乙醇体系或乙酸乙酯与丙酮体系;层析柱中的填料可以为硅胶和碱性氧化铝。本申请实施例方案中,选用乙酸乙酯与甲醇体系,乙酸乙酯与甲醇比例为(6~10):1,因乙酸乙酯与甲醇均廉价易得,也可以乙酸乙酯与乙醇体系或乙酸乙酯与丙酮体系替代。In this application, the eluent used in the separation process of column chromatography can be ethyl acetate and methanol system, ethyl acetate and ethanol system or ethyl acetate and acetone system; the filler in the column can be silica gel and Basic alumina. In the embodiments of the present application, the system of ethyl acetate and methanol is selected, and the ratio of ethyl acetate to methanol is (6~10): 1. Because both ethyl acetate and methanol are cheap and easy to obtain, the system of ethyl acetate and ethanol or ethyl acetate and acetone system instead.
本申请所提供的去甲基奥洛他定的合成方法,在现有技术的基础上,对关键步骤进行了升级改造,具有以下优点:The synthetic method of desmethyl olopatadine provided by the present application, on the basis of the prior art, has carried out upgrading and transformation to key steps, and has the following advantages:
1、通过替换初始原料,将整体的反应步骤由4步缩减至2步,合成中间体以及合成去甲基奥洛他定,合成路线如下式所示,节约物料,有效提高总产率:1. By replacing the initial raw materials, the overall reaction steps are reduced from 4 steps to 2 steps, and the synthesis of intermediates and the synthesis of desmethyl olopatadine. The synthetic route is shown in the following formula, which saves materials and effectively improves the total yield:
; ;
。 .
2、改善反应条件,有效降低杂质与异构体生成,提高目标产物收率;2. Improve the reaction conditions, effectively reduce the generation of impurities and isomers, and improve the yield of the target product;
3、降低后处理难度同时保证质量和收率;3. Reduce the difficulty of post-processing while ensuring quality and yield;
4、优化了后处理条件,剔除了超高温苛刻反应,降低对设备的依赖;4. The post-processing conditions are optimized, ultra-high temperature harsh reactions are eliminated, and the dependence on equipment is reduced;
5、整体反应简单易操作,且合成稳定无特殊要求,适合工业化生产。5. The overall reaction is simple and easy to operate, and there are no special requirements for stable synthesis, which is suitable for industrial production.
以下通过具体实施例对本发明作进一步说明。The present invention will be further described below through specific embodiments.
实施例1Example 1
一、(3-甲氨基丙基)三苯基溴化膦合成1. Synthesis of (3-methylaminopropyl) triphenylphosphine bromide
四口瓶中加入异丙醇150g,三苯基膦26.2g和(3-溴丙基)(N-甲基)胺氢溴酸盐28.0g。氮气保护下,80℃搅拌15小时。减压蒸馏至干,加水150g,加二氯甲烷300g,分液保留有机相,有机相以50g 20%氢氧化钠溶液搅洗,分液保留有机相,有机相以20g无水硫酸钠干燥后蒸馏至干,加入四氢呋喃50g,升温至65℃,再降温至0℃,抽滤得白色固体,该固体置于烘箱中60℃烘至恒重。得(3-甲氨基丙基)三苯基溴化膦27.1g,本步收率65.5%。Add 150 g of isopropanol, 26.2 g of triphenylphosphine and 28.0 g of (3-bromopropyl) (N-methyl)amine hydrobromide to the four-necked flask. Under nitrogen protection, the mixture was stirred at 80°C for 15 hours. Vacuum distillation to dryness, add 150 g of water, add 300 g of dichloromethane, separate the organic phase to retain the organic phase, stir and wash the organic phase with 50 g of 20% sodium hydroxide solution, separate the organic phase to retain the organic phase, and dry the organic phase with 20 g of anhydrous sodium sulfate. Distilled to dryness, 50 g of tetrahydrofuran was added, the temperature was raised to 65° C., then cooled to 0° C., and a white solid was obtained by suction filtration. The solid was dried in an oven at 60° C. to constant weight. 27.1 g of (3-methylaminopropyl) triphenylphosphine bromide was obtained, and the yield in this step was 65.5%.
二、N-去甲基奥洛他定合成2. Synthesis of N-desmethyl olopatadine
三口瓶中加入(3-甲氨基丙基)三苯基溴化膦20.7g,再加入100g无水四氢呋喃,开启搅拌,控温20℃,加入17g 30%氢化钾 ,加完后升温至65℃,反应1h。然后加入10.7g伊索克酸,65℃搅拌2小时,再降温至8℃,缓慢加入3g无水甲醇,再加入40g 质量浓度为50%的四氢呋喃水溶液,最后加入160g水淬灭反应。反应液以浓盐酸(质量浓度为30%)调PH=7.5,然后减压蒸馏至干,干品经柱层析(乙酸乙酯:甲醇=9:1)(200~300目柱层析硅胶)得成品N-去甲基奥洛他定,HPLC检测结果如图1和表1所示,纯度99.78%(Z/E= 99.78:0.22),产量7.9g,本步收率61.3%。Add 20.7g of (3-methylaminopropyl) triphenylphosphine bromide in the there-necked flask, then add 100g of anhydrous tetrahydrofuran, turn on stirring, control the temperature to 20°C, add 17g of 30% potassium hydride, be warming up to 65°C after adding , the reaction is 1h. Then add 10.7g of isokic acid, stir at 65°C for 2 hours, then cool down to 8°C, slowly add 3g of anhydrous methanol, then add 40g of 50% tetrahydrofuran aqueous solution, and finally add 160g of water to quench the reaction. The reaction solution was adjusted to pH=7.5 with concentrated hydrochloric acid (30% by mass), then distilled under reduced pressure to dryness, and the dry product was subjected to column chromatography (ethyl acetate:methanol=9:1) (200~300 mesh column chromatography on silica gel) ) to obtain the finished product N-desmethylolopatadine, the HPLC detection results are shown in Figure 1 and Table 1, the purity is 99.78% (Z/E=99.78:0.22), the yield is 7.9g, and the yield in this step is 61.3%.
表1Table 1
实施例2Example 2
一、(3-氨基丙基)三苯基溴化膦合成1. Synthesis of (3-aminopropyl)triphenylphosphine bromide
四口瓶中加入异丙醇150g,三苯基膦26.2g和3-溴丙胺氢溴酸盐26.3g。氮气保护下,80℃搅拌15小时。减压蒸馏至干,加水150g,加二氯甲烷300g,分液保留有机相,有机相以50g 20%氢氧化钠溶液搅洗,分液保留有机相,有机相以20g无水硫酸钠干燥后蒸馏至干,加入四氢呋喃50g,升温至65℃,再降温至0℃,抽滤得白色固体,该固体置于烘箱中60℃烘至恒重。得(3-氨基丙基)三苯基溴化膦20.1g,本步收率64.9%。Add 150g of isopropanol, 26.2g of triphenylphosphine and 26.3g of 3-bromopropylamine hydrobromide to the four-necked bottle. Under nitrogen protection, the mixture was stirred at 80°C for 15 hours. Vacuum distillation to dryness, add 150 g of water, add 300 g of dichloromethane, separate the organic phase to retain the organic phase, stir and wash the organic phase with 50 g of 20% sodium hydroxide solution, separate the organic phase to retain the organic phase, and dry the organic phase with 20 g of anhydrous sodium sulfate. Distilled to dryness, 50 g of tetrahydrofuran was added, the temperature was raised to 65° C., then cooled to 0° C., and a white solid was obtained by suction filtration. The solid was dried in an oven at 60° C. to constant weight. 20.1 g of (3-aminopropyl) triphenylphosphine bromide was obtained, and the yield in this step was 64.9%.
二、N,N-去二甲基奥洛他定合成2. Synthesis of N,N-Desdimethylolopatadine
三口瓶中加入(3-氨基丙基)三苯基溴化膦20.0g,再加入100g无水四氢呋喃,开启搅拌,控温20℃,加入17g 30%氢化钾 ,加完后升温至65℃,反应1h。然后加入10.7g伊索克酸,65℃搅拌2小时,再降温至8℃,缓慢加入3g无水甲醇,再加入40g 质量浓度为50%的四氢呋喃水溶液,最后加入160g水淬灭反应。反应液以浓盐酸(质量浓度为30%)调PH=8.0,然后减压蒸馏至干,干品经柱层析(乙酸乙酯:甲醇=9:1)(200~300目柱层析硅胶)得成品N,N-去甲基奥洛他定,HPLC检测结果如图2和表2所示,纯度99.71%(Z/E= 99.76:0.18),产量7.8g,本步收率60.5%。Add 20.0 g of (3-aminopropyl) triphenylphosphine bromide in the there-necked flask, then add 100 g of anhydrous tetrahydrofuran, turn on stirring, control the temperature to 20 ° C, add 17 g of 30% potassium hydride, be warming up to 65 ° C after adding, Reaction for 1h. Then add 10.7g of isokic acid, stir at 65°C for 2 hours, then cool down to 8°C, slowly add 3g of anhydrous methanol, then add 40g of 50% tetrahydrofuran aqueous solution, and finally add 160g of water to quench the reaction. The reaction solution was adjusted to pH=8.0 with concentrated hydrochloric acid (30% by mass), then distilled under reduced pressure to dryness, and the dry product was subjected to column chromatography (ethyl acetate:methanol=9:1) (200~300 mesh column chromatography on silica gel) ) to obtain the finished product N,N-desmethyl olopatadine, the HPLC detection results are shown in Figure 2 and Table 2, the purity is 99.71% (Z/E=99.76:0.18), the output is 7.8g, and the yield in this step is 60.5% .
表2Table 2
实施例3Example 3
一、(3-甲氨基丙基)三苯基溴化膦合成1. Synthesis of (3-methylaminopropyl) triphenylphosphine bromide
四口瓶中加入异丙醇200g,三苯基膦34.1g和(3-溴丙基)(N-甲基)胺氢溴酸盐36.4g。氮气保护下,76℃搅拌13小时。减压蒸馏至干,加水200g,加二氯甲烷400g,分液保留有机相,有机相以70g 20%氢氧化钠溶液搅洗,分液保留有机相,有机相以30g无水硫酸钠干燥后蒸馏至干,加入四氢呋喃65g,升温至60℃,再降温至2℃,抽滤得白色固体,该固体置于烘箱中65℃烘至恒重。得(3-甲氨基丙基)三苯基溴化膦35.1g,本步收率65.2%。Add 200 g of isopropanol, 34.1 g of triphenylphosphine and 36.4 g of (3-bromopropyl) (N-methyl)amine hydrobromide to the four-necked flask. Under nitrogen protection, the mixture was stirred at 76°C for 13 hours. Vacuum distillation to dryness, add 200 g of water, add 400 g of dichloromethane, separate the organic phase to retain the organic phase, stir and wash the organic phase with 70 g of 20% sodium hydroxide solution, separate the organic phase to retain the organic phase, and dry the organic phase with 30 g of anhydrous sodium sulfate. Distilled to dryness, added 65 g of tetrahydrofuran, heated to 60°C, then cooled to 2°C, suction filtered to obtain a white solid, which was dried in an oven at 65°C to constant weight. 35.1 g of (3-methylaminopropyl) triphenylphosphine bromide was obtained, and the yield in this step was 65.2%.
二、N-去甲基奥洛他定合成2. Synthesis of N-desmethyl olopatadine
三口瓶中加入(3-甲氨基丙基)三苯基溴化膦26.9g,再加入150g无水四氢呋喃,开启搅拌,控温22℃,加入19g 35%氢化钾 ,加完后升温至62℃,反应2h。然后加入13.9g伊索克酸,62℃搅拌3小时,再降温至6℃,缓慢加入4g无水甲醇,再加入65g 质量浓度为40%的四氢呋喃水溶液,最后加入200g水淬灭反应。反应液以浓盐酸(质量浓度为30%)调PH=7.2,然后减压蒸馏至干,干品经柱层析(乙酸乙酯:甲醇=7:1)(200~300目柱层析硅胶)得成品N-去甲基奥洛他定,HPLC检测结果如图3和表3所示,纯度99.76%(Z/E= 99.71:0.22),产量10.1g,本步收率60.1%。Add (3-methylaminopropyl) triphenylphosphine bromide 26.9g in the there-necked flask, then add 150g of anhydrous tetrahydrofuran, turn on stirring, control temperature to 22°C, add 19g of 35% potassium hydride, be warming up to 62°C after adding , the reaction 2h. Then add 13.9g isoxocic acid, stir at 62°C for 3 hours, then cool to 6°C, slowly add 4g of anhydrous methanol, then add 65g of tetrahydrofuran aqueous solution with a mass concentration of 40%, and finally add 200g of water to quench the reaction. The reaction solution was adjusted to pH=7.2 with concentrated hydrochloric acid (30% by mass), then distilled under reduced pressure to dryness, and the dry product was subjected to column chromatography (ethyl acetate:methanol=7:1) (200~300 mesh column chromatography on silica gel) ) to obtain the finished product N-desmethylolopatadine, the HPLC detection results are shown in Figure 3 and Table 3, the purity is 99.76% (Z/E=99.71:0.22), the yield is 10.1 g, and the yield in this step is 60.1%.
表3table 3
实施例4Example 4
一、(3-氨基丙基)三苯基溴化膦合成1. Synthesis of (3-aminopropyl)triphenylphosphine bromide
四口瓶中加入异丙醇200g,三苯基膦34.1g和3-溴丙胺氢溴酸盐34.2g。氮气保护下,77℃搅拌14小时。减压蒸馏至干,加水200g,加二氯甲烷400g,分液保留有机相,有机相以72g 20%氢氧化钠溶液搅洗,分液保留有机相,有机相以30g无水硫酸钠干燥后蒸馏至干,加入四氢呋喃65g,升温至61℃,再降温至1℃,抽滤得白色固体,该固体置于烘箱中63℃烘至恒重。得(3-氨基丙基)三苯基溴化膦26.2g,本步收率64.8%。Add 200g of isopropanol, 34.1g of triphenylphosphine and 34.2g of 3-bromopropylamine hydrobromide to the four-necked bottle. Under nitrogen protection, the mixture was stirred at 77°C for 14 hours. Vacuum distillation to dryness, add 200 g of water, add 400 g of dichloromethane, separate the organic phase and retain the organic phase, stir and wash the organic phase with 72 g of 20% sodium hydroxide solution, separate the organic phase and retain the organic phase, after the organic phase is dried with 30 g of anhydrous sodium sulfate Distilled to dryness, 65 g of tetrahydrofuran was added, the temperature was raised to 61° C., then cooled to 1° C., and a white solid was obtained by suction filtration, which was dried in an oven at 63° C. to constant weight. 26.2 g of (3-aminopropyl) triphenylphosphine bromide was obtained, and the yield in this step was 64.8%.
二、N,N-去二甲基奥洛他定合成2. Synthesis of N,N-Desdimethylolopatadine
三口瓶中加入(3-氨基丙基)三苯基溴化膦26.0g,再加入160g无水四氢呋喃,开启搅拌,控温23℃,加入20g 35%氢化钾 ,加完后升温至62℃,反应1.5h。然后加入13.9g伊索克酸,64℃搅拌2.5小时,再降温至7℃,缓慢加入4g无水甲醇,再加入44g 质量浓度为60%的四氢呋喃水溶液,最后加入200g水淬灭反应。反应液以浓盐酸(质量浓度为30%)调PH=8.2,然后减压蒸馏至干,干品经柱层析(乙酸乙酯:甲醇=8:1)(200~300目柱层析硅胶)得成品N,N-去甲基奥洛他定,纯度99.83%(Z/E= 99.83:0.17),HPLC检测结果如图4和表4所示,产量9.8g,本步收率61.3%。In the there-necked flask, add 26.0 g of (3-aminopropyl) triphenylphosphine bromide, then add 160 g of anhydrous tetrahydrofuran, start stirring, control the temperature to 23 ° C, add 20 g of 35% potassium hydride, be warming up to 62 ° C after adding, The reaction was carried out for 1.5h. Then 13.9 g of isokic acid was added, stirred at 64 °C for 2.5 hours, then cooled to 7 °C, slowly added with 4 g of anhydrous methanol, then added with 44 g of an aqueous solution of tetrahydrofuran with a mass concentration of 60%, and finally added 200 g of water to quench the reaction. The reaction solution was adjusted to pH=8.2 with concentrated hydrochloric acid (30% by mass), then distilled under reduced pressure to dryness, and the dry product was subjected to column chromatography (ethyl acetate:methanol=8:1) (200~300 mesh column chromatography on silica gel) ) to obtain finished product N,N-desmethyl olopatadine, purity 99.83% (Z/E=99.83:0.17), HPLC detection result is shown in Figure 4 and Table 4, output 9.8g, this step yield 61.3% .
表4Table 4
通过上述实施例可以看出,本申请方法通过缩减反应步骤,成功合成N-去甲基奥洛他定和N,N-去二甲基奥洛他定,总收率达到39.2%,具有很好的工业应用价值。采用本申请方法制备得到的N-去甲基奥洛他定和N,N-去二甲基奥洛他定99.7%,可运用于化学分析,亦可用于生物性质研究或作为医药中间体进一步合成。It can be seen from the above examples that the method of the present application has successfully synthesized N-desmethyl olopatadine and N,N-desmethyl olopatadine by reducing the reaction steps, and the total yield reaches 39.2%, which has a high yield. Good industrial application value. 99.7% of N-desmethyl olopatadine and N,N-desdimethyl olopatadine prepared by the method of the present application can be used for chemical analysis, biological property research or further as a pharmaceutical intermediate synthesis.
应当理解的是,本申请的应用不限于上述的举例,对本领域普通技术人员来说,可以根据上述说明加以改进或变换,所有这些改进和变换都应属于本申请所附权利要求的保护范围。It should be understood that the application of the present application is not limited to the above examples. For those of ordinary skill in the art, improvements or transformations can be made according to the above descriptions, and all these improvements and transformations should belong to the protection scope of the appended claims of the present application.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210016513.6A CN114276384A (en) | 2022-01-07 | 2022-01-07 | Synthetic method of desmethyl olopatadine and its intermediates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210016513.6A CN114276384A (en) | 2022-01-07 | 2022-01-07 | Synthetic method of desmethyl olopatadine and its intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114276384A true CN114276384A (en) | 2022-04-05 |
Family
ID=80880461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210016513.6A Pending CN114276384A (en) | 2022-01-07 | 2022-01-07 | Synthetic method of desmethyl olopatadine and its intermediates |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114276384A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118240312A (en) * | 2024-04-12 | 2024-06-25 | 浙江佳洁塑胶有限公司 | Preparation method of wear-resistant PVC bathroom anti-slip pad |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007110761A2 (en) * | 2006-03-28 | 2007-10-04 | Universität Zürich | Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof |
CN102149701A (en) * | 2008-07-16 | 2011-08-10 | 拉贾迪乌斯公司 | Process for obtaining olopatadine and intermediates |
CN110343086A (en) * | 2019-08-07 | 2019-10-18 | 重庆西南制药二厂有限责任公司 | A kind of preparation method of Olopatadine hydrochloride |
WO2019239152A1 (en) * | 2018-06-15 | 2019-12-19 | Seren Technologies Limited | Rare earth metal oxide preparation |
-
2022
- 2022-01-07 CN CN202210016513.6A patent/CN114276384A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007110761A2 (en) * | 2006-03-28 | 2007-10-04 | Universität Zürich | Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof |
CN102149701A (en) * | 2008-07-16 | 2011-08-10 | 拉贾迪乌斯公司 | Process for obtaining olopatadine and intermediates |
WO2019239152A1 (en) * | 2018-06-15 | 2019-12-19 | Seren Technologies Limited | Rare earth metal oxide preparation |
CN110343086A (en) * | 2019-08-07 | 2019-10-18 | 重庆西南制药二厂有限责任公司 | A kind of preparation method of Olopatadine hydrochloride |
Non-Patent Citations (1)
Title |
---|
JIANGSHENG XU等: ""A Mitochondria-targeted and NO-based Anticancer Nanosystem with Enhanced Photo-controllability and Low Dark-toxicity"", 《JOURNAL OF MATERIALS CHEMISTRY B》, vol. 3, pages 4904 - 4912 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118240312A (en) * | 2024-04-12 | 2024-06-25 | 浙江佳洁塑胶有限公司 | Preparation method of wear-resistant PVC bathroom anti-slip pad |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106866553B (en) | Synthesis method of Favipiravir | |
AU2014339136B2 (en) | Process for the preparation of a PDE4 inhibitor | |
CN110818760A (en) | A kind of production technology of industrialized synthesis of dydrogesterone | |
JP2009531408A (en) | Polymorphic form of olopatadine hydrochloride and process for producing olopatadine and its salts | |
AU2014339136A1 (en) | Process for the preparation of a PDE4 inhibitor | |
CN114276384A (en) | Synthetic method of desmethyl olopatadine and its intermediates | |
CN113121416A (en) | Preparation method of lefenacin | |
CN108358900A (en) | A kind of preparation method of Afatinib and its maleate | |
CN110183445A (en) | The synthetic method of Moxifloxacin and its derivative | |
CN101605773B (en) | Process for production of dibenzoxepin compound | |
CN113336703B (en) | Synthesis of 1,3,4, 5-tetrasubstituted 1H-pyrazole derivatives | |
CN112920053B (en) | Preparation method of chiral alpha-methyl aromatic ethylamine | |
CN114478290A (en) | Synthetic method of oseltamivir intermediate | |
CN109574860B (en) | Method for preparing vilanterol | |
CN115160174A (en) | Synthesis method of ioversol | |
CN111116593B (en) | Continuous preparation method of imatinib | |
CN101356158B (en) | A new intermediate for making montelukast and related compounds | |
CN111606898A (en) | A kind of posaconazole related substance and its preparation method and use | |
CN112457287A (en) | Preparation method of E-olopatadine | |
CN115141237B (en) | A preparation method of rosavidin intermediate | |
CN116396330B (en) | Preparation method of cyclopropyl substituted 2H-benzopyran derivative | |
CN111039838B (en) | Preparation method of 3-acetylmercapto-2-methylpropanoic acid | |
WO2011116491A1 (en) | Preparation method for nortropine benzilate and its salts and intermediates used in said method | |
CN111662293A (en) | Preparation method of zeatin | |
CN115385932A (en) | Intermediate of pyridone derivative and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220405 |